PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic mapping and exome sequencing identify variants associated with five novel diseases.
|
22279524 |
2012 |
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Genetic mapping and exome sequencing identify variants associated with five novel diseases.
|
22279524 |
2012 |
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic mapping and exome sequencing identify variants associated with five novel diseases.
|
22279524 |
2012 |
Aortic Valve Stenosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Macroglossia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Macrostomia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Bicuspid aortic valve
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Subglottic stenosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Horizontal Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypoplasia of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Epilepsy, Rolandic
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy.
|
29358611 |
2018 |
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital exomphalos
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Leukoencephalopathy, Progressive Multifocal
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Only the isoform-specific sequences of PML-I and PML-V are highly conserved between man and mouse.
|
16778193 |
2006 |
Leukoencephalopathy, Progressive Multifocal
|
0.030 |
Biomarker
|
disease |
BEFREE |
There was a selective requirement of PML isoform in NFAT activation: PML-I and PML-VI, but not PML-IV, increased NFAT transactivation.
|
18246125 |
2008 |
Leukoencephalopathy, Progressive Multifocal
|
0.030 |
Biomarker
|
disease |
BEFREE |
PML I was able to recruit AML1 and coactivator p300 in PML nuclear bodies and enhance the AML1-mediated transcription in the presence of p300.
|
15331439 |
2005 |
Non-Small Cell Lung Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
High expression of SNIP1 correlates with poor prognosis in non-small cell lung cancer and SNIP1 interferes with the recruitment of HDAC1 to RB in vitro.
|
23932364 |
2013 |
Non-Small Cell Lung Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The significant association of SNIP1 and c-Myc staining in a non-small cell lung cancer tissue array is further evidence that their activities might be linked and suggests that SNIP1 might be an important modulator of c-Myc activity in carcinogenesis.
|
17157259 |
2006 |
Fibroid Tumor
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
|
20651370 |
2010 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We obtained metastasized melanoma tissue from a primary acral lentiginous melanoma (ALM) patient and established a melanoma cell line named primary culture of melanoma cell derived from lymph node (PML)-1.
|
19759547 |
2010 |
Neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Finally, PML-I and TSP2 expression inversely correlates with tumor angiogenesis and recurrence in localized neuroblastomas.
|
27076624 |
2016 |
Schizophrenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A trend toward association was found between schizophrenia and (i) genotype 11 of the Pml I polymorphism (p = 0.034; OR = 1.82); (ii) haplotype 1-2 for the Pml I and Bcl I polymorphisms (p = 0.022; OR = 1.75).
|
10490696 |
1999 |
Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings may indicate the involvement of SNIP1 in progression of lung cancer by regulating the RB/HDAC1 interaction.
|
23932364 |
2013 |